Skip to content
2000
Volume 17, Issue 15
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

After the discovery and characterization of the H3R and H4R receptors, they have become widely anticipated as potential therapeutic agents in the treatment of sleep disorders. In preliminary studies, histamine H3 receptor (H3R) antagonists and inverse agonists have demonstrated promise in the treatment of sleep disorders associated with excessive daytime sleepiness. This review article summarizes the current research in this area and characteristics of H3R and H3R antagonists and inverse agonists in development.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161211796197133
2011-05-01
2025-05-05
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161211796197133
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test